![Michael Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Fleming
Director/Board Member at
SONA NANOTECH INC.
Profile
Michael A. Fleming is currently Director at Sona Nanotech, Inc. since 2026.
Former roles include Senior Vice President-Commercial & Tysabri Brand at Elan Corp.
Plc, Head-Hematology Marketing at Genentech, Inc., Vice President-Commercial Operations at Nuvelo, Inc., Vice President-HIV Oncology Vaccines Business Unit at GlaxoSmithKline, Inc., and Chief Strategy Officer at Coherus Oncology, Inc. from 2021 to 2022.
Education includes an MBA from Rotman School of Management and undergraduate studies at Victoria College (Canada).
Michael Fleming active positions
| Companies | Position | Start |
|---|---|---|
| SONA NANOTECH INC. | Director/Board Member | 11/06/2026 |
Former positions of Michael Fleming
| Companies | Position | End |
|---|---|---|
| COHERUS ONCOLOGY, INC. | Corporate Officer/Principal | 01/01/2022 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | - |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Corporate Officer/Principal | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | - |
Training of Michael Fleming
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
46
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Nuvelo, Inc.
Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Coherus BioSciences, Inc.
 Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Victoria College (Canada)
 Victoria College (Canada) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sona Nanotech, Inc.
 Sona Nanotech, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures rod-shaped gold nanoparticles | Process Industries |
- Stock Market
- Insiders
- Michael Fleming
